XRRA1
gene geneOn this page
Also known as FLJ00225
Summary
XRRA1 (X-ray radiation resistance associated 1, HGNC:18868) is a protein-coding gene on chromosome 11q13.4, encoding X-ray radiation resistance-associated protein 1 (Q6P2D8). May be involved in the response of cells to X-ray radiation.
Involved in response to X-ray. Located in cytoplasm and nuclear body.
Source: NCBI Gene 143570 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 143 total
- MANE Select transcript:
NM_001378157
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18868 |
| Approved symbol | XRRA1 |
| Name | X-ray radiation resistance associated 1 |
| Location | 11q13.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ00225 |
| Ensembl gene | ENSG00000166435 |
| Ensembl biotype | protein_coding |
| OMIM | 609788 |
| Entrez | 143570 |
Gene structure
Transcript identifiers
Ensembl transcripts: 22 — 8 protein_coding, 7 protein_coding_CDS_not_defined, 4 retained_intron, 3 nonsense_mediated_decay
ENST00000321448, ENST00000340360, ENST00000431210, ENST00000524430, ENST00000525407, ENST00000526047, ENST00000527087, ENST00000528219, ENST00000528819, ENST00000529400, ENST00000529926, ENST00000530280, ENST00000530562, ENST00000531449, ENST00000531849, ENST00000531852, ENST00000533598, ENST00000533990, ENST00000534041, ENST00000534798, ENST00000684022, ENST00000705661
RefSeq mRNA: 23 — MANE Select: NM_001378157
NM_001270380, NM_001270381, NM_001378157, NM_001378158, NM_001378159, NM_001378160, NM_001378161, NM_001378162, NM_001378163, NM_001378164, NM_001378165, NM_001378166, NM_001378167, NM_001378168, NM_001378169, NM_001378170, NM_001378171, NM_001378172, NM_001378173, NM_001378174, NM_001378175, NM_001378176, NM_182969
CCDS: CCDS44680, CCDS58159, CCDS58160, CCDS91535
Canonical transcript exons
ENST00000684022 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001242559 | 74862981 | 74863021 |
| ENSE00001470150 | 74945018 | 74945085 |
| ENSE00001549403 | 74859158 | 74859283 |
| ENSE00001705069 | 74840910 | 74843453 |
| ENSE00002180994 | 74948928 | 74949091 |
| ENSE00003473450 | 74930300 | 74930372 |
| ENSE00003474061 | 74848115 | 74848462 |
| ENSE00003496123 | 74921214 | 74921347 |
| ENSE00003504981 | 74927391 | 74927488 |
| ENSE00003535437 | 74907145 | 74907273 |
| ENSE00003537031 | 74851088 | 74851203 |
| ENSE00003557327 | 74843854 | 74843959 |
| ENSE00003574045 | 74936884 | 74937068 |
| ENSE00003603215 | 74906239 | 74906456 |
| ENSE00003614024 | 74845073 | 74845271 |
| ENSE00003652614 | 74844168 | 74844283 |
| ENSE00003662008 | 74933801 | 74933872 |
| ENSE00003684932 | 74851989 | 74852082 |
| ENSE00003993947 | 74940785 | 74940882 |
Expression profiles
Bgee: expression breadth ubiquitous, 172 present calls, max score 92.23.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.0364 / max 143.4450, expressed in 1779 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121331 | 8.7504 | 1757 |
| 121332 | 3.2861 | 1272 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 92.23 | gold quality |
| left testis | UBERON:0004533 | 91.75 | gold quality |
| right testis | UBERON:0004534 | 91.07 | gold quality |
| testis | UBERON:0000473 | 89.25 | gold quality |
| bone marrow cell | CL:0002092 | 87.78 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.49 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.49 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.65 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 81.98 | gold quality |
| colonic epithelium | UBERON:0000397 | 81.81 | gold quality |
| right uterine tube | UBERON:0001302 | 80.97 | gold quality |
| corpus callosum | UBERON:0002336 | 80.92 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.50 | gold quality |
| granulocyte | CL:0000094 | 80.18 | gold quality |
| muscle of leg | UBERON:0001383 | 79.74 | gold quality |
| gall bladder | UBERON:0002110 | 79.70 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.42 | gold quality |
| adrenal tissue | UBERON:0018303 | 79.30 | gold quality |
| right lobe of liver | UBERON:0001114 | 78.85 | gold quality |
| pancreas | UBERON:0001264 | 78.60 | gold quality |
| sperm | CL:0000019 | 78.55 | gold quality |
| body of pancreas | UBERON:0001150 | 78.53 | gold quality |
| ventricular zone | UBERON:0003053 | 78.52 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.21 | gold quality |
| left ovary | UBERON:0002119 | 78.08 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 78.06 | gold quality |
| right coronary artery | UBERON:0001625 | 77.98 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.95 | gold quality |
| body of uterus | UBERON:0009853 | 77.95 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.00 |
| E-MTAB-6386 | no | 638.75 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
84 targeting XRRA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-7978 | 99.86 | 66.90 | 856 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
Literature-anchored findings (GeneRIF, showing 3)
- Molecular cloning and gene expression patterns of XRRA1. (PMID:12908878)
- our results identify a novel link between XRRA1 and the ATM/CHK1/2 pathway and suggest that XRRA1 is involved in a DNA damage response that drives radio- and chemoresistance by regulating the ATM/CHK1/2 pathway. (PMID:29082250)
- Genetic architecture of asthma in African American patients. (PMID:36089080)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | xrra1 | ENSDARG00000089578 |
| mus_musculus | Xrra1 | ENSMUSG00000035211 |
| rattus_norvegicus | Xrra1 | ENSRNOG00000026503 |
Protein
Protein identifiers
X-ray radiation resistance-associated protein 1 — Q6P2D8 (reviewed: Q6P2D8)
All UniProt accessions (9): A0A804HIK0, A0A994J5L1, E9PIR2, Q6P2D8, E9PJ58, E9PL06, E9PMT6, E9PP69, H0YD10
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in the response of cells to X-ray radiation.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Expressed predominantly in testis followed by prostate and ovary. Low levels found in other tissues including peripheral blood leukocytes, spleen, thymus, small intestine and colon. Also expressed in neuroblastoma, glioma, breast, lung, leukemia, renal, ovarian, prostate and colorectal cancer cell lines.
Induction. By X-ray irradiation immediately after exposure and is then down-regulated two-fold in an X-ray radiation-resistant cell clone. Responds differently to X-ray radiation in clones of varying radiation responses.
Miscellaneous. Gene model based on mouse cDNA data.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6P2D8-1 | 1 | yes |
| Q6P2D8-2 | 2 | |
| Q6P2D8-3 | 3 | |
| Q6P2D8-4 | 4 | |
| Q6P2D8-5 | 5 |
RefSeq proteins (23): NP_001257309, NP_001257310, NP_001365086, NP_001365087, NP_001365088, NP_001365089, NP_001365090, NP_001365091, NP_001365092, NP_001365093, NP_001365094, NP_001365095, NP_001365096, NP_001365097, NP_001365098, NP_001365099, NP_001365100, NP_001365101, NP_001365102, NP_001365103, NP_001365104, NP_001365105, NP_892014 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
UniProt features (24 total): splice variant 7, repeat 6, sequence conflict 3, region of interest 3, sequence variant 2, chain 1, coiled-coil region 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6P2D8-F1 | 55.86 | 0.10 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
GOBP_RESPONSE_TO_IONIZING_RADIATION, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, chr11q13, GOBP_RESPONSE_TO_RADIATION, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, GOBP_RESPONSE_TO_X_RAY, GOCC_NUCLEAR_BODY, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN, GSE14415_NATURAL_TREG_VS_TCONV_DN, CIITA_TARGET_GENES, DYRK1A_TARGET_GENES, E2F5_TARGET_GENES, ID1_TARGET_GENES
GO Biological Process (1): response to X-ray (GO:0010165)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), nucleoplasm (GO:0005654), cytoplasm (GO:0005737), nuclear body (GO:0016604)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| response to ionizing radiation | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
673 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| XRRA1 | XRCC5 | P13010 | 775 |
| XRRA1 | SPCS2 | Q15005 | 470 |
| XRRA1 | GPALPP1 | Q8IXQ4 | 454 |
| XRRA1 | CLLU1-AS1 | Q5K130 | 447 |
| XRRA1 | MAN2C1 | Q9NTJ4 | 405 |
| XRRA1 | SLFN5 | Q08AF3 | 398 |
| XRRA1 | CHRDL2 | Q6WN34 | 381 |
| XRRA1 | C2orf74 | A8MZ97 | 377 |
| XRRA1 | SAMD10 | Q9BYL1 | 377 |
| XRRA1 | CCDC126 | Q96EE4 | 370 |
| XRRA1 | ARMCX2 | Q7L311 | 368 |
| XRRA1 | ANKRD30B | Q9BXX2 | 355 |
| XRRA1 | ZNF502 | Q8TBZ5 | 349 |
| XRRA1 | ZNF880 | Q6PDB4 | 349 |
| XRRA1 | METTL27 | Q8N6F8 | 348 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| XRRA1 | HSP90B1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| XRRA1 | H1-2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| XRRA1 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| DYRK2 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.350 |
| XRRA1 | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (11): XRRA1 (Affinity Capture-RNA), XRRA1 (Affinity Capture-MS), XRRA1 (Synthetic Lethality), XRRA1 (Proximity Label-MS), XRRA1 (Proximity Label-MS), KIAA0232 (Affinity Capture-MS), HSPA8 (Affinity Capture-MS), XRRA1 (Affinity Capture-MS), PPM1K (Cross-Linking-MS (XL-MS)), XRRA1 (Cross-Linking-MS (XL-MS)), XRRA1 (Affinity Capture-RNA)
ESM2 similar proteins: A0A0M3U1B0, A0A1L8EYB2, A2AGB2, A2ALV5, A3KMW7, A6NM62, A8MT70, A9JRX0, D3Z987, P15975, P56716, P70347, Q0P5X5, Q0VET5, Q28FY7, Q2M2Z5, Q3MHT3, Q3U0P1, Q3U3V8, Q3UXL4, Q3V089, Q5SXH7, Q5T1N1, Q5T4T6, Q5VXU9, Q68CR7, Q6NZK5, Q6P2D8, Q7M6U3, Q7Z4H7, Q7Z572, Q7ZYI3, Q7ZZH7, Q80VP2, Q86T90, Q86YC2, Q8BG34, Q8BL06, Q8CCC3, Q8MJ03
Diamond homologs: Q15813, Q32KS0, Q3U3V8, Q5FVQ9, Q5RBD9, Q6P2D8, Q7PCK7, Q8CIV8, Q8GRL7, Q95LL2, A1Z6J5, B9EHT4, Q5R686, Q5U243, Q5U378, Q5U508, Q96DZ5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
143 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 111 |
| Likely benign | 13 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4295 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:74810182:AGCT:A | acceptor_gain | 1.0000 |
| 11:74810183:GCT:G | acceptor_gain | 1.0000 |
| 11:74810183:GCTG:G | acceptor_gain | 1.0000 |
| 11:74817713:GG:G | donor_gain | 1.0000 |
| 11:74817714:GG:G | donor_gain | 1.0000 |
| 11:74818043:G:GT | donor_gain | 1.0000 |
| 11:74835541:TTCA:T | acceptor_loss | 1.0000 |
| 11:74835542:TCAG:T | acceptor_loss | 1.0000 |
| 11:74835543:CAGGT:C | acceptor_loss | 1.0000 |
| 11:74836678:G:GT | donor_gain | 1.0000 |
| 11:74844131:AGGGG:A | donor_gain | 1.0000 |
| 11:74844281:TTC:T | acceptor_gain | 1.0000 |
| 11:74844282:TC:T | acceptor_gain | 1.0000 |
| 11:74844283:CC:C | acceptor_gain | 1.0000 |
| 11:74844283:CCTA:C | acceptor_loss | 1.0000 |
| 11:74844284:C:A | acceptor_loss | 1.0000 |
| 11:74844284:C:CC | acceptor_gain | 1.0000 |
| 11:74844285:T:A | acceptor_loss | 1.0000 |
| 11:74844290:C:CT | acceptor_gain | 1.0000 |
| 11:74845070:TACC:T | donor_loss | 1.0000 |
| 11:74845071:AC:A | donor_gain | 1.0000 |
| 11:74845072:C:CA | donor_loss | 1.0000 |
| 11:74845072:CC:C | donor_gain | 1.0000 |
| 11:74845267:CTCAC:C | acceptor_gain | 1.0000 |
| 11:74848110:GGTAC:G | donor_loss | 1.0000 |
| 11:74848112:TACC:T | donor_loss | 1.0000 |
| 11:74848113:A:T | donor_loss | 1.0000 |
| 11:74848114:C:CA | donor_loss | 1.0000 |
| 11:74851203:CCTGG:C | acceptor_gain | 1.0000 |
| 11:74851211:C:CT | acceptor_gain | 1.0000 |
AlphaMissense
5209 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:74859162:T:A | N381I | 0.998 |
| 11:74906445:A:G | L258S | 0.998 |
| 11:74859177:A:G | L376P | 0.997 |
| 11:74906430:T:A | N263I | 0.997 |
| 11:74907208:A:G | L233P | 0.997 |
| 11:74852011:G:C | N406K | 0.996 |
| 11:74852011:G:T | N406K | 0.996 |
| 11:74852051:G:T | A393D | 0.996 |
| 11:74859161:G:C | N381K | 0.996 |
| 11:74859161:G:T | N381K | 0.996 |
| 11:74859186:A:G | L373P | 0.996 |
| 11:74907169:A:G | F246S | 0.996 |
| 11:74859163:T:A | N381Y | 0.995 |
| 11:74859173:G:C | S377R | 0.995 |
| 11:74859173:G:T | S377R | 0.995 |
| 11:74859175:T:G | S377R | 0.995 |
| 11:74859186:A:T | L373Q | 0.995 |
| 11:74907192:G:C | N238K | 0.995 |
| 11:74907192:G:T | N238K | 0.995 |
| 11:74852036:A:T | L398H | 0.994 |
| 11:74852045:A:G | F395S | 0.994 |
| 11:74859177:A:T | L376H | 0.994 |
| 11:74859195:A:G | F370S | 0.994 |
| 11:74906429:G:C | N263K | 0.994 |
| 11:74906429:G:T | N263K | 0.994 |
| 11:74906431:T:A | N263Y | 0.994 |
| 11:74906431:T:G | N263H | 0.994 |
| 11:74907202:A:G | L235P | 0.994 |
| 11:74907208:A:T | L233Q | 0.994 |
| 11:74921271:A:G | L192P | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000003493 (11:74900279 T>C), RS1000011833 (11:74949044 C>G), RS1000060760 (11:74867575 G>A), RS1000074357 (11:74861626 T>C), RS1000135373 (11:74914725 G>A,T), RS1000144931 (11:74843064 G>T), RS1000171144 (11:74942992 C>T), RS1000172663 (11:74890142 C>T), RS1000174159 (11:74935030 C>A,G), RS1000191311 (11:74854991 A>G), RS1000232757 (11:74885749 G>A), RS1000264116 (11:74885943 A>C), RS1000313094 (11:74935820 T>C,G), RS1000326374 (11:74884840 A>G,T), RS1000354914 (11:74899971 C>T)
Disease associations
OMIM: gene MIM:609788 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, affects splicing, increases abundance | 2 |
| trichostatin A | affects expression | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic | affects splicing, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.